Current Therapeutic Research

Oral bisphosphonates in the treatment of osteoporosis: a review
pp. 831-851(21)
Author: Francis R.M.

Intravenous ampicillin/sulbactam versus cefuroxime axetil in the treatment of patients hospitalized with community-acquired lower respiratory tract infections
pp. 852-862(11)
Authors: Rossoff L.J.; Hilton E.; Smith C.; Isenberg H.D.; McKeon Simme M.

Cilazapril in arterial hypertension: effect on the trough-to-peak ratio and on ambulatory blood pressure recorded in an office setting
pp. 863-872(10)
Authors: Leeman M.; Van De Borne P.; Lanoy M.; Haazen L.; Degaute J.-P.

Inhibition of bacterial regrowth in the puerperal uterine cavity of flomoxef
pp. 873-878(6)
Authors: Mikamo H.; Kawazoe K.; Izumi K.; Bandoh K.; Katoh N.; Watanabe K.; Ueno K.; Tamaya T.

Low-dose cyclosporine in the treatment of patients with psoriasis: experience in Hong Kong
pp. 879-886(8)
Authors: Chong L.-Y.; Look C.-N.; Fung C.-W.; Ho K.-M.

Effect of omeprazole and lansoprazole on serum pepsinogen A levels in patients with duodenal ulcer
pp. 887-893(7)
Authors: Chang F.-Y.; Lee C.-T.; Chiang C.-Y.; Lee S.-D.

Lysine clonixinate versus aspirin in the treatment of gonarthrosis
pp. 894-905(12)
Authors: Cayetti L.M.; De Los Santos A.R.; Marti M.L.; Di Girolamo G.; Niselman V.

Doppler-ultrasound pilot study of the effects of long-term policosanol therapy on carotid-vertebral atherosclerosis
pp. 906-914(9)
Authors: Batista J.; Stusser R.; Penichet M.; Uguet E.

Five-day azithromycin in the treatment of patients with community-acquired pneumonia
pp. 915-925(11)
Authors: Hopkins S.; Williams D.

Trials in special populations - Editorial comment
pp. 927-927(1)
Author: Walson P.D.

Chloroquine phosphate suppositories in the treatment of childhood malaria in Calabar, Nigeria
pp. 928-935(8)
Authors: Antia-Obong O.E.; Alaribe A.A.A.; Young M.U.; Bassey A.; Etim B.V.

Introduction
pp. 938-939(2)
Author: Ayuso-Gutierrez J.

The need for extended-release medications
pp. 940-946(7)
Author: Alexander P.E.

Clinical pharmacokinetics of alprazolam extended release: a summary
pp. 947-956(10)
Author: Wright C.E.

Alprazolam extended release in the management of anxiety
pp. 957-965(9)
Author: Figueira M.L.

Once-a-day control of panic disorder: evidence from a placebo-controlled trial of alprazolam extended release
pp. 966-968(3)
Author: Schweizer E.

Discontinuation of benzodiazepines in patients with anxiety disorders: a focus on alprazolam and alprazolam extended release
pp. 969-974(6)
Author: Klein E.

Practical considerations in the use of alprazolam XR
pp. 975-980(6)